Literature DB >> 14512708

Treatment-seeking inpatient cocaine abusers show hypothalamic dysregulation of both basal prolactin and cortisol secretion.

Carlo Contoreggi1, Ronald I Herning, Bonnie Koeppl, Pippa M Simpson, Paulo J Negro, Carolyn Fortner-Burton, Judith Hess.   

Abstract

Cocaine causes neuroendocrine aberrations in cocaine abusers with pituitary stress hormone secretion providing a window to the stress system in the brain. Substance abusers and control participants were hormonally profiled for 3 weeks. Abusers showed significant basal elevations in prolactin in week 1 with normalization over the 3 weeks. No differences in prolactin secretion were seen with either thyrotropin-releasing hormone stimulation or L-dopa suppression testing. Basal afternoon cortisol secretion was significantly elevated during weeks 1 and 2 comparing abusers to controls. Elevated afternoon cortisol secretion is a sensitive indicator of central stress activation. These results point to the hypothalamus, not the pituitary gland, as being primarily altered in cocaine withdrawal. The data demonstrate that both the dopamine-prolactin and hypothalamic-pituitary-adrenal (HPA) axes are affected during cocaine cessation. As medications are developed to modulate activation of a dysfunctional stress system, future therapeutic studies of substance abuse, withdrawal, craving and relapse should employ more sophisticated tests of hypothalamic pituitary function, especially the HPA axis, as this information may be a guide in the diagnosis and predict clinical responses. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512708     DOI: 10.1159/000072797

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  17 in total

Review 1.  Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.

Authors:  Tong H Lee; Steven T Szabo; J Corey Fowler; Paolo Mannelli; O Barry Mangum; Wayne F Beyer; Ashwin Patkar; William C Wetsel
Journal:  Drug Alcohol Depend       Date:  2012-02-21       Impact factor: 4.492

2.  Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes.

Authors:  Helen C Fox; Eric D Jackson; Rajita Sinha
Journal:  Psychoneuroendocrinology       Date:  2009-04-16       Impact factor: 4.905

3.  Persistent increase in hypothalamic arginine vasopressin gene expression during protracted withdrawal from chronic escalating-dose cocaine in rodents.

Authors:  Yan Zhou; Yoav Litvin; Anna Paola Piras; Donald W Pfaff; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2011-06-15       Impact factor: 7.853

4.  An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.

Authors:  L Antkiewicz-Michaluk; M Filip; J Michaluk; I Romańska; E Przegaliński; J Vetulani
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

5.  Peripheral blood microRNA levels in females with cocaine use disorder.

Authors:  Thiago Wendt Viola; Bernardo Aguzzoli Heberle; Aline Zaparte; Breno Sanvicente-Vieira; Leonardo Mendes Wainer; Gabriel Rodrigo Fries; Consuelo Walss-Bass; Rodrigo Grassi-Oliveira
Journal:  J Psychiatr Res       Date:  2019-04-02       Impact factor: 4.791

6.  Higher n-3 fatty acids are associated with more intense fenfluramine-induced ACTH and cortisol responses among cocaine-abusing men.

Authors:  Laure Buydens-Branchey; Marc Branchey; Joseph R Hibbeln
Journal:  Psychiatry Res       Date:  2011-06-11       Impact factor: 3.222

7.  Dysregulation of diurnal cortisol secretion affects abstinence induction during a lead-in period of a clinical trial for depressed cocaine-dependent patients.

Authors:  Wilfrid Noel Raby; Lisa Sanfilippo; Martina Pavlicova; Kenneth M Carpenter; Andrew Glass; Chukwudi Onyemekwu; Eric Roginek; Edward V Nunes
Journal:  Am J Addict       Date:  2013-05-30

8.  Elevated plasma prolactin in abstinent methamphetamine-dependent subjects.

Authors:  Todd Zorick; Mark A Mandelkern; Buyean Lee; Ma-Li Wong; Karen Miotto; Jon Shabazian; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2010-12-10       Impact factor: 3.829

9.  Gonadal and Adrenal Abnormalities in Drug Users: Cause or Consequence of Drug Use Behavior and Poor Health Outcomes.

Authors:  Todd T Brown; Amy B Wisniewski; Adrian S Dobs
Journal:  Am J Infect Dis       Date:  2006

10.  Daily cocaine self-administration under long-access conditions augments restraint-induced increases in plasma corticosterone and impairs glucocorticoid receptor-mediated negative feedback in rats.

Authors:  John R Mantsch; William E Cullinan; Lee C Tang; David A Baker; Eric S Katz; Michael A Hoks; Dana R Ziegler
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.